Elsevier

Peptides

Volume 11, Issue 6, November–December 1990, Pages 1239-1244
Peptides

Article
Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell lines

https://doi.org/10.1016/0196-9781(90)90158-2Get rights and content

Abstract

We investigated the molecular and pharmacologic characteristics of VIP receptors on two human SCLC cell lines: NCI-N592 and NCI-H345. With NCI-N592 cell, the order of potency of VIP-related peptides in inhibiting 125I-VIP binding and in stimulating cAMP production was typical of the human VIP receptor. By covalent cross-linking, a polypeptide of Mr 62,300 was obtained. Conversely, the behavior of NCI-H345 cell line was totally different: helodermin was the most potent peptide, VIP and PHI were equipotent, while hGRF and secretin were totally ineffective. These results suggest that NCI-N592 cells possess a typical VIP receptor while NCI-H345 cells possess a helodermin-preferring receptor, and that the natural target of helodermin might not be the VIP receptor.

References (34)

  • P. Robberecht et al.

    Presence of helodermin-like peptides of the VIP-secretin family in mammalian salivary glands and saliva

    FEBS Lett.

    (1985)
  • P. Robberecht et al.

    A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts

    FEBS Lett.

    (1988)
  • P. Robberecht et al.

    Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes

    Regul. Pept.

    (1989)
  • M.M. Shaffer et al.

    High affinity binding of VIP to human lung cancer cell lines

    Peptides

    (1987)
  • K. Abe et al.

    Hormone-producing lung cancers. Endocrinologic and morphologic studies

  • D. Bataille et al.

    Interaction of glucagon, gut glucagon, vasoactive intestinal peptide and secretin with liver and fat cell membranes: Binding to specific sites and stimulation of adenylate cyclase

    Endocrinology

    (1974)
  • D.N. Carney et al.

    Establishment and identification of small cell lung carcinoma cell lines having classic and variant features

    Cancer Res.

    (1985)
  • Cited by (38)

    • Bioactive peptides from lizard venoms

      1996, Regulatory Peptides
    View all citing articles on Scopus
    View full text